Results of percutaneous cervical vertebroplasty using an anterolateral approach for cervical spine tumors

Acta Orthop Traumatol Turc. 2022 Jul;56(4):268-271. doi: 10.5152/j.aott.2022.22035.


Objective: The aim of this study was to report the results of percutaneous vertebroplasty in managing symptomatic osteolytic cervical spine tumors.

Methods: This study comprised a retrospective examination of patients who received percutaneous vertebroplasty between 2008 and 2020 for the treatment of tumor-induced symptomatic cervical vertebra involvement. The study summarized the demographics, vertebral levels, pain control rates, clinical results, and complications of percutaneous vertebroplasty using an anterolateral approach.

Results: The study sample consisted of 6 female and 2 male patients aged between 20 and 56 (mean=41.37) years. Tumors were located at C2 in 6 cases, at C3 in 1 case, and at C5 in another. The mean volume of poly (methyl methacrylate) injected was 1.5 mL (range: 1-2 mL). Biopsy results showed the presence of metastasis in 5 cases and plasmacytoma in 3. No postoperative complications or mortality were observed after the procedure. Preoperative mean 7.75 visual analog scale score decreased to 2.62. Pain control was reported to be 66.2%.

Conclusion: Anterolateral cervical vertebroplasty seems to be a safe, effective, and helpful therapeutic alternative for the treatment of cervical spine tumors. It reduces the risk of infection compared to the transoral method.

Level of evidence: Level IV, Therapeutic Study.

MeSH terms

  • Adult
  • Cervical Vertebrae / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain / etiology
  • Polymethyl Methacrylate / therapeutic use
  • Retrospective Studies
  • Spinal Neoplasms* / complications
  • Spinal Neoplasms* / surgery
  • Vertebroplasty* / methods
  • Young Adult


  • Polymethyl Methacrylate